Form 4: Definitive Healthcare Director Sastry Chilukuri Granted Over 55,000 Restricted Stock Units

Definitive Healthcare Corp. Director Sastry Chilukuri was granted 55,911 restricted stock units, increasing his beneficial ownership to 126,794 shares, as disclosed in a recent SEC Form 4 filing.

Summary

• Chilukuri Sastry, a Director of Definitive Healthcare Corp. (DH), acquired 55,911 shares of Class A Common Stock in the form of Restricted Stock Units (RSUs).
• The transaction occurred on June 5, 2025, with a reported price of $0 per unit, typical for RSU grants.
• Following this acquisition, Mr. Chilukuri's total beneficial ownership in Definitive Healthcare Corp. stands at 126,794 shares.
• These RSUs represent a contingent right to receive one share of Class A Common Stock each and are subject to vesting.
• The vesting schedule for these RSUs is the earlier of June 5, 2026, or the date of the Issuer's next annual meeting of stockholders, contingent upon Mr. Chilukuri's continued service.

Sentiment

Score: 6

Explanation: The grant of equity to a director is generally a positive sign of alignment and retention, though it's a routine compensation event and not indicative of significant operational news.

Positives

• The grant of 55,911 Restricted Stock Units to Director Sastry Chilukuri aligns his interests with those of shareholders, incentivizing long-term performance and retention.
• The increase in beneficial ownership to 126,794 shares demonstrates continued commitment from a key board member.

Negatives

• No negative information is disclosed in this Form 4 filing.

Risks

• The vesting of the Restricted Stock Units is subject to the Reporting Person's continued service through the applicable vesting date, meaning the shares are not guaranteed if service ceases.

Future Outlook

The 55,911 Restricted Stock Units granted to Director Sastry Chilukuri are scheduled to vest on the earlier of June 5, 2026, or the date of the Issuer's next annual meeting of stockholders, contingent on his continued service.

Industry Context

This Form 4 filing details an individual insider transaction and does not provide broader industry context or trends. Equity grants to directors are a standard practice across various industries for compensation and alignment.

Comparison to Industry Standards

• This Form 4 filing is a standard disclosure of an insider equity grant. The grant of Restricted Stock Units to a director is a common form of executive and board compensation across publicly traded companies, including those in the healthcare technology sector. Without specific details on the company's compensation philosophy or peer group data, a direct comparison of the grant size to industry benchmarks is not possible from this document alone.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with shareholders by tying compensation to future stock performance and continued service.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• Vesting of the 55,911 Restricted Stock Units on the earlier of June 5, 2026, or the date of the Issuer's next annual meeting of stockholders, subject to continued service.

Key Dates

Keywords

Definitive Healthcare, DH, Chilukuri Sastry, Restricted Stock Units, RSU, Insider Transaction, Form 4, Director Compensation, Equity Grant, Beneficial Ownership